| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0022215115002777 |
| P698 | PubMed publication ID | 26467493 |
| P2093 | author name string | L Flood | |
| M Bahgat | |||
| N Dawe | |||
| P2860 | cites work | Non-surgical interventions for eosinophilic esophagitis | Q24236562 |
| Distinguishing GERD from eosinophilic oesophagitis: concepts and controversies | Q26860824 | ||
| An audit of endoscopic complications in adult eosinophilic esophagitis | Q28239780 | ||
| Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment | Q28252340 | ||
| Eosinophilic esophagitis | Q28278849 | ||
| Common variants at 5q22 associate with pediatric eosinophilic esophagitis | Q28943383 | ||
| High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. | Q30554334 | ||
| Development of a validated patient-reported symptom metric for pediatric eosinophilic esophagitis: qualitative methods. | Q31041358 | ||
| Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis | Q33934643 | ||
| Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999. | Q33972296 | ||
| Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. | Q53850475 | ||
| Escalating incidence of eosinophilic esophagitis: A 20-year prospective, population-based study in Olten County, Switzerland | Q58019861 | ||
| Delay in Diagnosis of Eosinophilic Esophagitis Increases Risk for Stricture Formation in a Time-Dependent Manner | Q61959718 | ||
| Long-Term Budesonide Maintenance Treatment Is Partially Effective for Patients With Eosinophilic Esophagitis | Q61959733 | ||
| Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years | Q61959798 | ||
| Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression | Q62616187 | ||
| Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome | Q70530791 | ||
| Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula | Q71737350 | ||
| Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids | Q74463947 | ||
| Treatment of eosinophilic esophagitis with inhaled corticosteroids | Q74788848 | ||
| Subglottic stenosis complicated by allergic esophagitis: case report | Q77517260 | ||
| Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study | Q80976879 | ||
| Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia | Q81950092 | ||
| Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study | Q83223125 | ||
| Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis | Q83809844 | ||
| Role of operative airway evaluation in children with recurrent croup: a retrospective cohort study | Q86023170 | ||
| Do you see what I see? Towards standardized reporting of endoscopic findings in eosinophilic esophagitis | Q86068318 | ||
| Do endoscopic features suggesting eosinophilic esophagitis represent histological eosinophilia? | Q86585888 | ||
| Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease | Q34003041 | ||
| Eosinophilic esophagitis: A subset of eosinophilic gastroenteritis | Q34027741 | ||
| Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis | Q34331377 | ||
| Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota | Q34518075 | ||
| Routine screening for eosinophilic esophagitis in patients presenting with dysphagia | Q34565699 | ||
| Pediatric patients with eosinophilic esophagitis: an 8-year follow-up | Q34574439 | ||
| Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study | Q34614300 | ||
| Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis | Q34619938 | ||
| Clinical and Endoscopic Features of Eosinophilic Esophagitis in Adults | Q35547704 | ||
| Eosinophilic oesophagitis: a novel treatment using Montelukast | Q35598391 | ||
| Eosinophilic esophagitis for the otolaryngologist. | Q35636150 | ||
| The Greater Cincinnati Pediatric Clinic Repository: A Novel Framework for Childhood Asthma and Allergy Research | Q36041398 | ||
| Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study | Q36072597 | ||
| A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease | Q36142507 | ||
| Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia | Q36153520 | ||
| The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis | Q36179681 | ||
| Otolaryngologic surgeries are frequent in children with eosinophilic esophagitis | Q36233085 | ||
| The management of foreign bodies in the pharynx and oesophagus using transnasal flexible laryngo-oesophagoscopy (TNFLO). | Q36411188 | ||
| Eosinophilic esophagitis in adults: what is the clinical significance? | Q36503428 | ||
| Airway manifestations of pediatric eosinophilic esophagitis: a clinical and histopathologic report of an emerging association | Q36561856 | ||
| Topical Steroid Therapy for the Treatment of Eosinophilic Esophagitis (EoE): A Systematic Review and Meta-Analysis. | Q36751852 | ||
| Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis | Q36832496 | ||
| Histopathologic features of eosinophilic esophagitis | Q37025134 | ||
| Eosinophilic esophagitis: association with allergic disorders | Q37025149 | ||
| Transnasal esophagoscopy: a position statement from the American Bronchoesophagological Association (ABEA). | Q37116351 | ||
| Eosinophilic oesophagitis and other non-reflux inflammatory conditions of the oesophagus: diagnostic imaging and management | Q37227416 | ||
| Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy | Q37297069 | ||
| Eosinophilic esophagitis in children: a pathologic or clinicopathologic diagnosis? | Q37372300 | ||
| 14 years of eosinophilic esophagitis: clinical features and prognosis. | Q37378395 | ||
| Eosinophilic esophagitis in adults: An ear, nose, and throat perspective | Q37510784 | ||
| Otolaryngologists may not be doing enough to diagnose pediatric eosinophilic esophagitis | Q37592486 | ||
| Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis | Q37632442 | ||
| Prevalence of eosinophilic esophagitis in the United States | Q37634307 | ||
| Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children | Q46780087 | ||
| Eosinophilic esophagitis: a 10-year experience in 381 children | Q46856158 | ||
| The otolaryngologic manifestations in children with eosinophilic esophagitis | Q46976037 | ||
| Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases | Q47803571 | ||
| Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system | Q48636350 | ||
| Dysphagia and quality of life may improve with mometasone treatment in patients with eosinophilic esophagitis: a pilot study | Q48667177 | ||
| Evaluating the endoscopic reference score for eosinophilic esophagitis: moderate to substantial intra- and interobserver reliability. | Q51114324 | ||
| Diagnostic and therapeutic management of eosinophilic oesophagitis in children and adults: results from a Spanish registry of clinical practice. | Q51267822 | ||
| Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy. | Q51362483 | ||
| Clinical characteristics of eosinophilic esophagitis in children. | Q51958056 | ||
| An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. | Q53226482 | ||
| A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. | Q53588622 | ||
| Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. | Q53604045 | ||
| Systematic review: the epidemiology of eosinophilic oesophagitis in adults. | Q37776000 | ||
| Review article: oesophageal dilation in adults with eosinophilic oesophagitis | Q37841683 | ||
| Eosinophilic esophagitis: updated consensus recommendations for children and adults | Q37863307 | ||
| Food hypersensitivity and otolaryngologic conditions in young children | Q37996986 | ||
| Eosinophilic esophagitis: diagnostic tests and criteria | Q37997348 | ||
| Atypical croup: association with airway lesions, atopy, and esophagitis | Q38010351 | ||
| Safety of dilation in adults with eosinophilic esophagitis | Q38016961 | ||
| Incidence and prevalence of eosinophilic esophagitis in children. | Q38094052 | ||
| ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). | Q38097271 | ||
| Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis | Q38105162 | ||
| Meta-analysis: the safety and efficacy of dilation in eosinophilic oesophagitis | Q38126551 | ||
| Prevalence of eosinophilic esophagitis in children with refractory aerodigestive symptoms | Q38139785 | ||
| Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. | Q38188754 | ||
| Practical approach to implementing dietary therapy in adults with eosinophilic esophagitis: the Chicago experience. | Q38193913 | ||
| Historical aspects of eosinophilic esophagitis: from case reports to clinical trials | Q38194005 | ||
| Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis | Q38248758 | ||
| A review of the evidence linking eosinophilic esophagitis and food allergy | Q38308719 | ||
| Pediatric patients with chronic cough and recurrent croup: the case for a multidisciplinary approach | Q38394315 | ||
| Eosinophilic Laryngitis in Children with Aerodigestive Dysfunction. | Q38395237 | ||
| Eosinophilic esophagitis: historical perspective on an evolving disease | Q39195382 | ||
| Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation | Q39295334 | ||
| Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults | Q39393073 | ||
| The pharyngeal mucosa is not involved in eosinophilic oesophagitis | Q39972638 | ||
| How do gastroenterologists assess overall activity of eosinophilic esophagitis in adult patients? | Q41319565 | ||
| Endoscopic mucosal tissue sampling | Q42282939 | ||
| Is the etiology of eosinophilic esophagitis in adults a response to allergy or reflux injury? Study of cellular proliferation markers | Q42449148 | ||
| The optimal number of biopsy fragments to establish a morphologic diagnosis of eosinophilic esophagitis | Q42452781 | ||
| Prevalence of esophageal eosinophils in patients with Barrett's esophagus | Q42483709 | ||
| High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults | Q42524960 | ||
| Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis | Q42947882 | ||
| Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial | Q43067460 | ||
| Localized esophageal eosinophilia: Is it an early manifestation of eosinophilic esophagitis or a subtype of gastroesophageal reflux disease? | Q44113590 | ||
| Endoscopy in eosinophilic esophagitis: "feline" esophagus and perforation risk | Q44797494 | ||
| Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis | Q44946380 | ||
| Active eosinophilic esophagitis is associated with impaired elimination of budesonide by cytochrome P450 3A enzymes. | Q45097168 | ||
| Esophageal foreign bodies and eosinophilic esophagitis--the need for esophageal mucosal biopsy: a 12-year survey across pediatric subspecialties. | Q45902936 | ||
| Narrow-band imaging magnifying endoscopy in adult patients with eosinophilic esophagitis/esophageal eosinophilia and lymphocytic esophagitis. | Q45904521 | ||
| Foreign body impaction as presentation of eosinophilic esophagitis. | Q46003021 | ||
| Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis. | Q46031657 | ||
| Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro-oesophageal reflux disease on oesophageal biopsy material | Q46201214 | ||
| 3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults | Q46476279 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1156-1166 | |
| P577 | publication date | 2015-10-15 | |
| P1433 | published in | Journal of Laryngology and Otology | Q13739438 |
| P1476 | title | Eosinophilic oesophagitis: a systematic review for otolaryngologists | |
| P478 | volume | 129 |
| Q39368569 | Six-Food Elimination Diet and Topical Steroids are Effective for Eosinophilic Esophagitis: A Meta-Regression | cites work | P2860 |
Search more.